BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3
| Status: | Terminated |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/15/2018 |
| Start Date: | September 1, 2016 |
| End Date: | June 30, 2018 |
BUPrenorphine Facilitated Access and Supportive Treatment--AIM 3
The goal of this study is to test whether peer mentors (i.e., individuals with past opioid
addiction and prior incarceration) can facilitate entrance into buprenorphine (Suboxone)
treatment for individuals with opioid use disorder who were recently released from jail or
prison. In order to test whether it is helpful to have peer mentors paired with recently
released individuals, the investigators will conduct an 18 month study, recruiting 72
formerly incarcerated individuals and assigning them by chance selection (like flipping a
coin) to either a group that will receive peer mentorship or a group that will receive a
referral to a community clinic.
addiction and prior incarceration) can facilitate entrance into buprenorphine (Suboxone)
treatment for individuals with opioid use disorder who were recently released from jail or
prison. In order to test whether it is helpful to have peer mentors paired with recently
released individuals, the investigators will conduct an 18 month study, recruiting 72
formerly incarcerated individuals and assigning them by chance selection (like flipping a
coin) to either a group that will receive peer mentorship or a group that will receive a
referral to a community clinic.
BUPrenorphine Facilitated Access and Supportive Treatment (BUP-FAST) is a peer mentorship
intervention in which trained peer mentors will link formerly incarcerated individuals with
opioid use disorder to addiction treatment (i.e. buprenorphine maintenance treatment)
following release from incarceration. The current study is a pilot randomized control trial
evaluating the effectiveness and feasibility of the peer mentorship intervention.
The investigators are conducting this study due to the high rates of relapse to opioid use
following release from prison (up to 75% within 3 months) and difficulty that some formerly
incarcerated individuals report in accessing effective treatments for opioid use disorder.
The investigators hypothesize that having peer mentors - who themselves have experienced
incarceration and have had success with buprenorphine treatment for opioid use disorder -
assisting formerly incarcerated individuals in seeking treatment will result in higher rates
of linkage to care in comparison to referral to a community health center for buprenorphine
treatment.
In this 18-month randomized control trial of the BUP-FAST intervention, the investigators
will recruit 72 formerly incarcerated individuals with opioid use disorder; half will then be
randomized to receive the BUP-FAST intervention (peer mentorship); and the other half
(control) will receive referral to a community health center for assessment for buprenorphine
treatment. Medication will not be provided as part of this study. Participants will only
receive buprenorphine treatment if they meet appropriate medical criteria after assessment at
the community health center.
intervention in which trained peer mentors will link formerly incarcerated individuals with
opioid use disorder to addiction treatment (i.e. buprenorphine maintenance treatment)
following release from incarceration. The current study is a pilot randomized control trial
evaluating the effectiveness and feasibility of the peer mentorship intervention.
The investigators are conducting this study due to the high rates of relapse to opioid use
following release from prison (up to 75% within 3 months) and difficulty that some formerly
incarcerated individuals report in accessing effective treatments for opioid use disorder.
The investigators hypothesize that having peer mentors - who themselves have experienced
incarceration and have had success with buprenorphine treatment for opioid use disorder -
assisting formerly incarcerated individuals in seeking treatment will result in higher rates
of linkage to care in comparison to referral to a community health center for buprenorphine
treatment.
In this 18-month randomized control trial of the BUP-FAST intervention, the investigators
will recruit 72 formerly incarcerated individuals with opioid use disorder; half will then be
randomized to receive the BUP-FAST intervention (peer mentorship); and the other half
(control) will receive referral to a community health center for assessment for buprenorphine
treatment. Medication will not be provided as part of this study. Participants will only
receive buprenorphine treatment if they meet appropriate medical criteria after assessment at
the community health center.
Inclusion Criteria:
1. Current or prior (at the time of incarceration) opioid use disorder by DSM-V criteria
2. ≥ 18 years old
3. Fluent in English or Spanish
4. Released from incarceration in the last 4 weeks
Exclusion Criteria:
1. Current buprenorphine or methadone maintenance treatment
2. Pregnancy
We found this trial at
1
site
3550 Jerome Avenue
Bronx, New York 10467
Bronx, New York 10467
(718) 920-4321
Principal Investigator: Aaron D Fox, MD, MS
Phone: 917-583-1839
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials
